Di Giannuario A, Pieretti S, Luzi M, Loizzo A
Laboratorio di Farmacologia, Istituto Superiore di Sanità, Rome, Italy.
J Pharmacol Exp Ther. 1994 Feb;268(2):1040-50.
The effects of some beta-endorphin fragments with neuroleptic-like properties, i.e., tau-endorphin, des-tyr1-tau-endorphin (DT tau E), desenkephalin-tau-endorphin (DE tau E), in comparison with the dopaminergic antagonist haloperidol,- were studied on the EEG and behavioral alterations induced by beta-endorphin in the rabbit. beta-Endorphin administered i.c.v. (5-30 nmol) induced EEG nonconvulsive limbic seizures as well as EEG background and behavioral alterations which were antagonized by naloxone administered i.v. (1-2 mg/kg). Haloperidol, tau-endorphin, DT tau E and DE tau E were unable to prevent beta-endorphin-induced alterations when injected in a single dose i.v. (25-50 micrograms/kg), 15 min before beta-endorphin. Subchronic i.v. administration of DT tau E or DE tau E (25 micrograms/kg/day) for 4 consecutive days prevented completely EEG limbic seizures as well as EEG background and behavioral alterations induced by i.c.v. beta-endorphin injected 15 min after the fourth dose; however, haloperidol (30 micrograms/kg/day) administered with the same schedule as DT tau E or DE tau E was able to prevent only EEG epileptiform and EEG background alterations induced by beta-endorphin. tau-Endorphin administered i.v. for 4 consecutive days (25 micrograms/kg/day) did not consistently influence any of the beta-endorphin effects. Our results show that DT tau E and DE tau E, which are devoid of opioid activity, exert a strong antagonism on ictal seizures as well as on other EEG alterations and behavioral alterations induced by beta-endorphin, and suggest that the antagonism shown by these drugs and by haloperidol on the EEG effects induced by beta-endorphin are exerted at least in part through an indirect action, i.e., an interaction with the dopaminergic system.
研究了一些具有抗精神病样特性的β-内啡肽片段,即τ-内啡肽、去酪氨酰-τ-内啡肽(DT τ E)、去脑啡肽-τ-内啡肽(DE τ E),与多巴胺能拮抗剂氟哌啶醇相比,对β-内啡肽诱导的家兔脑电图(EEG)和行为改变的影响。脑室内注射β-内啡肽(5 - 30 nmol)可诱发EEG非惊厥性边缘叶癫痫发作以及EEG背景和行为改变,静脉注射纳洛酮(1 - 2 mg/kg)可拮抗这些改变。在β-内啡肽注射前15分钟静脉注射单剂量(25 - 50微克/千克)的氟哌啶醇、τ-内啡肽、DT τ E和DE τ E,均无法预防β-内啡肽诱导的改变。连续4天皮下注射DT τ E或DE τ E(25微克/千克/天)可完全预防第四剂注射后15分钟脑室内注射β-内啡肽所诱发的EEG边缘叶癫痫发作以及EEG背景和行为改变;然而,按照与DT τ E或DE τ E相同的给药方案给予氟哌啶醇(30微克/千克/天),仅能预防β-内啡肽诱导的EEG癫痫样放电和EEG背景改变。连续4天静脉注射τ-内啡肽(25微克/千克/天)对β-内啡肽的任何效应均无持续影响。我们的结果表明,缺乏阿片样活性的DT τ E和DE τ E对β-内啡肽诱发的发作性癫痫以及其他EEG改变和行为改变具有强烈的拮抗作用,并提示这些药物和氟哌啶醇对β-内啡肽诱导的EEG效应的拮抗作用至少部分是通过间接作用,即与多巴胺能系统相互作用来实现的。